132 related articles for article (PubMed ID: 34796703)
1. Racial, Ethnic, and Socioeconomic Disparities in Curative Treatment Receipt and Survival in Hepatocellular Carcinoma.
Wagle NS; Park S; Washburn D; Ohsfeldt RL; Rich NE; Singal AG; Kum HC
Hepatol Commun; 2022 May; 6(5):1186-1197. PubMed ID: 34796703
[TBL] [Abstract][Full Text] [Related]
2. Association Between Race/Ethnicity and Insurance Status with Outcomes in Patients with Hepatocellular Carcinoma.
Scaglione S; Adams W; Caines A; Devlin P; Mittal S; Singal AG; Parikh ND
Dig Dis Sci; 2020 Jun; 65(6):1669-1678. PubMed ID: 31643036
[TBL] [Abstract][Full Text] [Related]
3. Racial and Ethnic Differences in Presentation and Outcomes of Hepatocellular Carcinoma.
Rich NE; Hester C; Odewole M; Murphy CC; Parikh ND; Marrero JA; Yopp AC; Singal AG
Clin Gastroenterol Hepatol; 2019 Feb; 17(3):551-559.e1. PubMed ID: 29859983
[TBL] [Abstract][Full Text] [Related]
4. Racial, Ethnic, and Socioeconomic Disparities in Treatment Delay Among Patients With Hepatocellular Carcinoma in the United States.
Wagle NS; Park S; Washburn D; Ohsfeldt RL; Rich NE; Singal AG; Kum HC
Clin Gastroenterol Hepatol; 2023 May; 21(5):1281-1292.e10. PubMed ID: 35933076
[TBL] [Abstract][Full Text] [Related]
5. Racial and Ethnic Disparities in Hepatocellular Carcinoma Treatment Receipt in the United States: A Systematic Review and Meta-Analysis.
Wagle NS; Park S; Washburn D; Ohsfeldt R; Kum HC; Singal AG
Cancer Epidemiol Biomarkers Prev; 2024 Apr; 33(4):463-470. PubMed ID: 38252039
[TBL] [Abstract][Full Text] [Related]
6. Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma.
Mathur AK; Osborne NH; Lynch RJ; Ghaferi AA; Dimick JB; Sonnenday CJ
Arch Surg; 2010 Dec; 145(12):1158-63. PubMed ID: 21173289
[TBL] [Abstract][Full Text] [Related]
7. Mediation analyses of socioeconomic factors determining racial differences in the treatment of diffuse large B-cell lymphoma in a cohort of older adults.
Guadamuz JS; Ozenberger K; Qato DM; Ko NY; Saffore CD; Adimadhyam S; Cha AS; Moran KM; Sweiss K; Patel PR; Chiu BC; Calip GS
Medicine (Baltimore); 2019 Nov; 98(46):e17960. PubMed ID: 31725657
[TBL] [Abstract][Full Text] [Related]
8. Racial and Ethnic Disparities in Survival Among Patients With Hepatocellular Carcinoma in the United States: A Systematic Review and Meta-Analysis.
Rich NE; Carr C; Yopp AC; Marrero JA; Singal AG
Clin Gastroenterol Hepatol; 2022 Feb; 20(2):e267-e288. PubMed ID: 33387668
[TBL] [Abstract][Full Text] [Related]
9. Disparities in Breast Cancer Survival by Socioeconomic Status Despite Medicare and Medicaid Insurance.
Silber JH; Rosenbaum PR; Ross RN; Reiter JG; Niknam BA; Hill AS; Bongiorno DM; Shah SA; Hochman LL; Even-Shoshan O; Fox KR
Milbank Q; 2018 Dec; 96(4):706-754. PubMed ID: 30537364
[TBL] [Abstract][Full Text] [Related]
10. Survival disparities in non-small cell lung cancer by race, ethnicity, and socioeconomic status.
Tannenbaum SL; Koru-Sengul T; Zhao W; Miao F; Byrne MM
Cancer J; 2014; 20(4):237-45. PubMed ID: 25098282
[TBL] [Abstract][Full Text] [Related]
11. Disparities in Hepatocellular Carcinoma Incidence, Stage, and Survival: A Large Population-Based Study.
Flores YN; Datta GD; Yang L; Corona E; Devineni D; Glenn BA; Bastani R; May FP
Cancer Epidemiol Biomarkers Prev; 2021 Jun; 30(6):1193-1199. PubMed ID: 33737301
[TBL] [Abstract][Full Text] [Related]
12. Race, ethnicity, and socioeconomic status influence the survival of patients with hepatocellular carcinoma in the United States.
Artinyan A; Mailey B; Sanchez-Luege N; Khalili J; Sun CL; Bhatia S; Wagman LD; Nissen N; Colquhoun SD; Kim J
Cancer; 2010 Mar; 116(5):1367-77. PubMed ID: 20101732
[TBL] [Abstract][Full Text] [Related]
13. Disparities in adjuvant treatment of high-grade endometrial cancer in the Medicare population.
Corey L; Cote ML; Ruterbusch JJ; Vezina A; Winer I
Am J Obstet Gynecol; 2022 Apr; 226(4):541.e1-541.e13. PubMed ID: 34736911
[TBL] [Abstract][Full Text] [Related]
14. Black and Hispanic women are less likely than white women to receive guideline-concordant endometrial cancer treatment.
Kaspers M; Llamocca E; Quick A; Dholakia J; Salani R; Felix AS
Am J Obstet Gynecol; 2020 Sep; 223(3):398.e1-398.e18. PubMed ID: 32142825
[TBL] [Abstract][Full Text] [Related]
15. Association of County-Level Upward Economic Mobility with Stage at Diagnosis and Receipt of Curative-Intent Treatment among Patients with Hepatocellular Carcinoma.
Paro A; Dalmacy D; Tslimigras DI; Cloyd J; Ejaz A; Pawlik TM
Ann Surg Oncol; 2022 Aug; 29(8):5177-5185. PubMed ID: 35441305
[TBL] [Abstract][Full Text] [Related]
16. Racial and Ethnic Disparities in Use of Novel Hormonal Therapy Agents in Patients With Prostate Cancer.
Ma TM; Agarwal N; Mahal B; Barragan-Carrillo R; Spratt D; Rettig MB; Valle LF; Steinberg ML; Garraway I; Vapiwala N; Xiang M; Kishan AU
JAMA Netw Open; 2023 Dec; 6(12):e2345906. PubMed ID: 38039002
[TBL] [Abstract][Full Text] [Related]
17. Dissecting disease, race, ethnicity, and socioeconomic factors for hepatocellular carcinoma: An analysis from the United States Safety Net Collaborative.
Lee RM; Gamboa AC; Turgeon MK; Yopp A; Ryon EL; Kronenfeld JP; Goel N; Wang A; Lee AY; Luu S; Hsu C; Silberfein E; Maithel SK; Russell MC
Surg Oncol; 2020 Dec; 35():120-125. PubMed ID: 32871546
[TBL] [Abstract][Full Text] [Related]
18. Association between neutrophil-lymphocyte ratio, socioeconomic status, and ethnic minority with treatment outcome in hepatocellular carcinoma.
Zhang Y; Brodin NP; Ohri N; Thibaud S; Kaubisch A; Kinkhabwala M; Garg M; Guha C; Kabarriti R
Hepatol Int; 2019 Sep; 13(5):609-617. PubMed ID: 31372942
[TBL] [Abstract][Full Text] [Related]
19. Treatment Disparities Partially Mediate Socioeconomic- and Race/Ethnicity-Based Survival Disparities in Stage I-II Hepatocellular Carcinoma.
Swords DS; Newhook TE; Tzeng CD; Massarweh NN; Chun YS; Lee S; Kaseb AO; Ghobrial M; Vauthey JN; Tran Cao HS
Ann Surg Oncol; 2023 Nov; 30(12):7309-7318. PubMed ID: 37679537
[TBL] [Abstract][Full Text] [Related]
20. Treatment and outcomes of treating of hepatocellular carcinoma among Medicare recipients in the United States: a population-based study.
El-Serag HB; Siegel AB; Davila JA; Shaib YH; Cayton-Woody M; McBride R; McGlynn KA
J Hepatol; 2006 Jan; 44(1):158-66. PubMed ID: 16290309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]